Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined ...

Advances in screening and new therapies have transformed the outlook for people with lung cancer, one Colorado doctor says, ...

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

In a country where health challenges are often addressed too late and stress is a daily companion, one wellness professional is leading a quiet revolution—powered not by pills, but by nature itself.

The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated ...

An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The FDA has greenlighted Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for ...

(Reuters) -The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals and Roche's combination therapy as a maintenance treatment for adult patients with a type of lung cancer, the ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly (Reuters) -The U.S. Food and Drug Administration has ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals (JAZZ.O), opens new tab and Roche's (ROG.S), opens new tab combination therapy as a maintenance treatment for ...